Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition to a medicament containing same

Details for Australian Patent Application No. 2002356689 (hide)

Owner Sanofi-Aventis Deutschland GmbH

Inventors Heinelt, Uwe; Gekle, Michael; Bleich, Markus; Hofmeister, Armin; Wirth, Klaus; Lang, Hans-Jochen

Agent Watermark

Pub. Number AU-B-2002356689

PCT Number PCT/EP02/12990

PCT Pub. Number WO2003/048129

Priority 101 59 714.2 05.12.01 DE

Filing date 20 November 2002

Wipo publication date 17 June 2003

Acceptance publication date 15 May 2008

International Classifications

C07D 217/04 (2006.01) Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems

A61K 31/472 (2006.01) - Non-condensed isoquinolines, e.g. papaverine

A61K 31/4725 (2006.01)

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/5377 (2006.01)

A61P 1/10 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/14 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 11/16 (2006.01) Drugs for disorders of the respiratory system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 33/00 (2006.01) Antiparasitic agents

A61P 35/00 (2006.01) Antineoplastic agents

A61P 41/00 (2006.01) Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 217/14 (2006.01) Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems

C07D 217/16 (2006.01) Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems

C07D 217/18 (2006.01) Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

27 March 2003 Complete Application Filed

  Priority application(s): 101 59 714.2 05.12.01 DE

21 August 2003 Application Open to Public Inspection

  Published as AU-B-2002356689

22 December 2005 Assignment before Grant

  Aventis Pharma Deutschland GmbH The application has been assigned to Sanofi-Aventis Deutschland GmbH Assignments before Grant, Section 113

15 May 2008 Application Accepted

  Published as AU-B-2002356689

11 September 2008 Standard Patent Sealed

16 June 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002356690-Flavivirus NS1 subunit vaccine

2002356688-METHOD FOR THE PRODUCTION OF VINYL-ARENES, -HETEROARENES AND 1,3-DIENES FROM ARYL-, HETEROARYLOR VINYL-CARBOXYLIC ACID DERIVATIVES